Announce Date | 04/16/2025 |
EPS Normalized Actual | $1.1 (Beat by $0.121) |
EPS GAAP Actual | $1.1 (Beat by $0.121) |
Revenue Actual | $10.35B |
Revenue Surprise | Beat by $10350M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.10153 |
EPS GAAP Estimate | $1.10153 |
Revenue Estimate | $7.207397889B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.03 | 0.05059 | 10.35B | -1.1% | 3441.48M |
FQ4 2024 (Dec 2024) | 1.02 | -0.03185 | 6.979B | 3.55% | -23.38M |
FQ3 2024 (Sep 2024) | 1.1 | 0.11111 | 2.7B | -159.26% | -4200.12M |
FQ2 2024 (Jun 2024) | 1.03 | 0.0843 | 10.8B | 33.88% | 3989.98M |
FQ1 2024 (Mar 2024) | 0.85 | 0.01283 | 10.464B | 31.76% | 3751.75M |
FQ4 2023 (Dec 2023) | 0 | -0.68249 | 6.731B | 5.87% | -121.76M |
FQ3 2023 (Sep 2023) | 0.91 | 0.91 | 7B | 100% | 7000M |
FQ2 2023 (Jun 2023) | 0 | 0 | 7.141B | 100% | 7141M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
1.10153
Consensus Revenue Estimates
7.207397889B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.3401 | -- | 1.3401 | 1.3401 | 1 |
FQ3 2027 (Sep 2027) | 1.2798 | -- | 1.2798 | 1.2798 | 1 |
FQ2 2027 (Jun 2027) | 1.2661 | -- | 1.2661 | 1.2661 | 1 |
FQ1 2027 (Mar 2027) | 1.0681 | -- | 1.0681 | 1.0681 | 1 |
FQ4 2026 (Dec 2026) | 1.28654 | -- | 1.28654 | 1.28654 | 1 |
FQ3 2026 (Sep 2026) | 1.24628 | -- | 1.24628 | 1.24628 | 1 |
FQ2 2026 (Jun 2026) | 1.20716 | -- | 1.20716 | 1.20716 | 1 |
FQ1 2026 (Mar 2026) | 1.08359 | 4.95 | 1.08359 | 1.08359 | 1 |
FQ4 2025 (Dec 2025) | 1.14303 | 10.76 | 1.14303 | 1.14303 | 1 |
FQ3 2025 (Sep 2025) | 1.10153 | 0.14 | 1.10153 | 1.10153 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 15.47B | -- | 15.47B | 15.47B | 1 |
FQ3 2027 (Sep 2027) | 14.91B | -- | 14.91B | 14.91B | 1 |
FQ2 2027 (Jun 2027) | 14.38B | -- | 14.38B | 14.38B | 1 |
FQ1 2027 (Mar 2027) | 13.86B | -- | 13.86B | 13.86B | 1 |
FQ4 2026 (Dec 2026) | 7.63B | -- | 7.63B | 7.63B | 1 |
FQ3 2026 (Sep 2026) | 7.6B | -- | 7.6B | 7.6B | 1 |
FQ2 2026 (Jun 2026) | 7.46B | -- | 7.46B | 7.46B | 1 |
FQ1 2026 (Mar 2026) | 7.23B | -43.08 | 7.23B | 7.23B | 1 |
FQ4 2025 (Dec 2025) | 7.27B | 4.01 | 7.27B | 7.27B | 1 |
FQ3 2025 (Sep 2025) | 7.21B | 62.54 | 7.21B | 7.21B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.97941 | 1.03 | 0.05059 | 4.91% |
FQ4 2024 (Dec 2024) | 1.05185 | 1.02 | -0.03185 | -3.12% |
FQ3 2024 (Sep 2024) | 0.98889 | 1.1 | 0.11111 | 10.1% |
FQ2 2024 (Jun 2024) | 0.9457 | 1.03 | 0.0843 | 8.18% |
FQ1 2024 (Mar 2024) | 0.83717 | 0.85 | 0.01283 | 1.51% |
FQ4 2023 (Dec 2023) | 0.68249 | 0 | -0.68249 | -INF% |
FQ3 2023 (Sep 2023) | 0.91 | 0.91 | 100% | |
FQ2 2023 (Jun 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $6.91B | $10.35B | $3441.48M | 33.25% |
FQ4 2024 (Dec 2024) | $7B | $6.98B | $-23.38M | -0.33% |
FQ3 2024 (Sep 2024) | $6.9B | $2.7B | $-4200.12M | -155.56% |
FQ2 2024 (Jun 2024) | $6.81B | $10.8B | $3989.98M | 36.94% |
FQ1 2024 (Mar 2024) | $6.71B | $10.46B | $3751.75M | 35.85% |
FQ4 2023 (Dec 2023) | $6.85B | $6.73B | $-121.76M | -1.81% |
FQ3 2023 (Sep 2023) | $0B | $7B | $7000M | 100% |
FQ2 2023 (Jun 2023) | $0B | $7.14B | $7141M | 100% |